<?xml version="1.0" encoding="UTF-8"?>
<xml>
 <records>
  <record>
   <ref-type name="Journal Article">17</ref-type>
   <contributors>
    <authors>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
    </authors>
   </contributors>
   <titles>
    <title></title>
   </titles>
   <dates>
    <year>2020</year>
    <pub-dates>
     <date>2020-12-03</date>
    </pub-dates>
   </dates>
   <doi>10.1016/S0735-1097(20)30759-2</doi>
   <abstract>The biomarkes NT-proBNP, ST2 and Pentraxin-3 (Ptx-3) have emerged as potential powerful tools in stratifying the risk of unfavorable cardiovascular events in cardiac patients in post-MI period. Goal was to investigate the potential prognostic power of the biomarkers ST2, Ptx-3 andNT-proBNP in cardiovascular events risk stratification in 2 years FU after STEMI.</abstract>
   <urls>
    <web-urls>
     <url>https://repo.bashgmu.ru/publication/885</url>
    </web-urls>
    <pdf-urls>
     <url>https://repo.bashgmu.ru/files/1008</url>
    </pdf-urls>
   </urls>
  </record>
 </records>
</xml>
